Results 31 to 40 of about 41,794 (337)
Рациональная фармакотерапия в кардиологии, 2016 Aim. To evaluate the heart rate variability (HRV) in patients with ischemic heart disease (IHD) and paroxysmal atrial fibrillation (AF) during atorvastatin therapy.Material and methods.
E. S. Kozlova +3 more
doaj +1 more source
Frequency Analysis of Atrial Fibrillation From the Surface Electrocardiogram [PDF]
, 2004 Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice. Neither the natural history of AF nor its response to therapy are sufficiently predictable by clinical and echocardiographic parameters.
Bollmann, Andreas +4 more
core
Cardiac Potassium Channels: Physiological Insights for Targeted Therapy. [PDF]
, 2017 The development of novel drugs specifically directed at the ion channels underlying particular features of cardiac action potential (AP) initiation, recovery, and refractoriness would contribute to an optimized approach to antiarrhythmic therapy that ...
A. John Camm +14 more
core +1 more source
Advanced Science, EarlyView.This target trial emulation in solid organ transplant candidates with obesity and type 2 diabetes evaluates whether pre‐transplant dual therapy with GLP‐1 receptor agonists plus SGLT2 inhibitors is associated with post‐transplant mortality and kidney graft outcomes compared with monotherapy or usual care, using multinational electronic health records ...
Yu‐Nan Huang +7 more
wiley +1 more source
Quality of Life in Patients with Implantable Cardioverter Defibrillators [PDF]
, 2006 Background: The implantable cardioverter defibrillator (ICD) is a life saving device for individuals with life threatening ventricular arrhythmias. There is no doubt that it is a cost effective therapy in various congenital and acquired arrhythmogenic ...
Francis, Johnson +2 more
core +1 more source
Risk Stratification in Post-MI Patients Based on Left Ventricular Ejection Fraction and Heart-Rate Turbulence [PDF]
, 2003 Objectives: Development of risk stratification criteria for predicting mortality in post-infarction patients taking into account LVEF and heart-rate turbulence (HRT).
Barthel, Petra +6 more
core +1 more source
Continuous electrocardiogram monitoring in porcine model of myocardial ischemia reperfusion
Animal Models and Experimental Medicine, EarlyView.Wearable technology for continuous electrocardiogram monitoring can be utilized in porcine models of disease. Abstract As cardiovascular disease is the leading cause of global mortality, innovative animal models are vital to demonstrating the translational value of experimental discoveries. Investigations focused on myocardial remodeling after ischemia
Nathaniel Hyams +8 more
wiley +1 more source
Journal of Ginseng Research, 2020 Background: Malignant arrhythmias require drug therapy. However, most of the currently available antiarrhythmic drugs have significant side effects. Ginsenoside Rg2 exhibits excellent cardioprotective effects and appears to be a promising candidate for ...
Dongxia Gou +7 more
doaj +1 more source
Ablation as First-line Therapy for Atrial Fibrillation
European Cardiology Review, 2023 AF is a chronic and progressive heart rhythm disorder characterised by exacerbations and remissions. Contemporary guidelines recommend antiarrhythmic drugs (AADs) as the initial therapy for the maintenance of sinus rhythm. However, these medications have
Jason G Andrade
doaj +1 more source
Future evaluation of antiarrhythmic therapy
American Heart Journal, 1994 The expansion of antiarrhythmic therapy beyond pharmacologic agents to include surgery, devices, and ablation procedures, plus the reaffirmation by the Cardiac Arrhythmia Suppression Trial (CAST) of the need for concurrent placebo-controlled trials to establish a mortality benefit, have resulted in the need to consider the requirements for evaluating ...
R J, Myerburg +6 more
openaire +2 more sources